InsidersTradesSigma
CERNER Corp Stock: price and directors' dealings · United States · SEC (Form 4)
Track the CERNER Corp share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, CERNER Corp has logged 89 insider filings. The latest transaction was filed on 9 June 2022 (U). Among the most active insiders: Dalton Travis. All data is free.
89
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€2m
5 ops.
Sell Volume
30Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 June 2022
Declarations89 total
37,460 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035491:0
539 shares@ US$95.008.4% of flowCommon StockSEC:0001209191-22-035488:0
6,246 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035508:0
844 shares@ US$95.003.6% of flowCommon StockSEC:0001209191-22-035502:0
2,768 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035498:0
14,525 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035501:0
12,825 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035503:0
371 shares@ US$95.004.9% of flowCommon StockSEC:0001209191-22-035484:0
26,588 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035504:0
23,438 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035499:0
15,032 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035497:0
31,319 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035495:0
295 shares@ US$95.001.9% of flowCommon StockSEC:0001209191-22-035492:0
43,905 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035493:0
21,909 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035500:0
2,000 shares@ US$55.7415.8% of flowCommon StockSEC:0001209191-22-027636:0
1,729 shares0Common StockSEC:0001209191-22-026575:0
7,769 shares@ US$93.4031.8% of flowCommon StockSEC:0001209191-22-018181:0
15,000 shares@ US$67.2464.7% of flowCommon StockSEC:0001209191-22-017043:0
7,374 shares0Common StockSEC:0001209191-21-071600
7,374 shares0Common StockSEC:0001209191-21-071600:0
11,480 shares0Common StockSEC:0001209191-21-070954
5,549 shares0Common StockSEC:0001209191-21-070956
692 shares0Common StockSEC:0001209191-21-070940
4,407 shares0Common StockSEC:0001209191-21-070953
25 of 89 declarations
About CERNER Corp
Recent developments are dominated by post-acquisition integration rather than standalone corporate actions. Oracle has been repositioning the Cerner asset base under the Oracle Health banner, with a focus on cloud modernization, AI-enabled clinical tools, and tighter integration with Oracle’s broader data and application stack. In practical terms, that means Cerner’s former strategic themes—EHR modernization, workflow automation, interoperability, and hospital digitization—now sit inside Oracle’s healthcare strategy rather than a separate public company. As a result, SEC Form 4 insider-trading activity is associated with Oracle, not Cerner as an independent issuer. For French, Belgian, and Swiss investors, Cerner is best viewed as a historically important U.S. healthcare software franchise that has been folded into a much larger NASDAQ-listed parent, rather than as a separately traded stock.
